Abiopharma

🔍 Baumgartner Florian (Executive)

Company: CIMPRESS plc (CMPR)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 8,263 shares of Ordinary Shares (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 72,106.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,025 shares of Ordinary Shares (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 73,131.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,411 shares of Ordinary Shares at $80.49 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 68,720.00 | transaction_form_type: 4
• Sold 8,263 shares of Restricted Share Units (right to acquire) (Derivative)
  Date: 2026-04-15 | Code: M | Expires: 2026-04-15 | Exercise: 2023-04-15 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,025 shares of Restricted Share Units (right to acquire) (Derivative)
  Date: 2026-04-15 | Code: M | Expires: 2027-01-15 | Exercise: 2024-01-15 | equity_swap_involved: 0 | shares_owned_after: 3,077.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The shares acquired automatically vested pursuant to an award of restricted share units (RSUs), with each RSU representing Cimpress' commitment to issue one ordinary share.
• F2: These RSUs vest over the following four-year period: 25% of the original number of RSUs granted vest on the Date Exercisable in Table II and 25% of such number of RSUs vest yearly thereafter.
• F3: These RSUs vest over the following four-year period: 25% of the original number of RSUs granted vest on the Date Exercisable in Table II and 6.25% of such number of RSUs vest quarterly thereafter.